Depression and anxiety were each associated with a higher risk of major adverse cardiac events, with the greatest risk observed when both conditions co-occurred, and these associations were partly mediated by heightened stress-related neural activity and downstream autonomic and inflammatory dysregulation. In more than 85,000 participants from the Mass General Brigham Biobank (2010–2020) followed for a median of 3.4 years, depression increased the risk of major adverse cardiac events (hazard ratio, 1.24), an effect that was stronger for individuals with concurrent anxiety and depression (hazard ratio, 1.35) and remained significant after extensive adjustment for confounders. In subgroups with imaging and biomarker data, depression and anxiety were linked to higher amygdala-to-prefrontal cortex activity, reduced heart rate variability, and elevated C-reactive protein levels, all markers of stress-related autonomic and immune activation. Mediation analyses confirmed that these neural and physiological pathways partially explained the relationship between depression, anxiety and cardiac risk, highlighting shared stress-related mechanisms. Source: https://www.ahajournals.org/
The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…
Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…
Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…
Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…
Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…
In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…
This website uses cookies.